CWM
AGN

Cornerstone Wealth Management’s Allergan plc AGN Stock Holding History

Cornerstone Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-637
Closed -$452K – 528
2019
Q1 		$452K Buy
+637
New +$92.4K 0.05% 287
2018
Q1 		$249K Buy
1,531
+94
+7% +$15.8K 0.05% 325
2017
Q4 		$245K Buy
1,437
+70
+5% +$12.6K 0.05% 340
2017
Q3 		$276K Sell
1,367
-1
-0.1% -$233 0.06% 299
2017
Q2 		$331K Buy
1,368
+179
+15% +$42.1K 0.07% 256
2017
Q1 		$285K Buy
+1,189
New +$277K 0.07% 258

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cornerstone Wealth Management's AGN Position: Q2 2019 in Review

Cornerstone Wealth Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 637 shares — an estimated $452K sold.

Cornerstone Wealth Management first reported a position in AGN in Q1 2017 and held it in 6 quarters. The position peaked at $452K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Cornerstone Wealth Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Cornerstone Wealth Management sold 637 Allergan plc shares in Q2 2019, an estimated $452K.
  • Cornerstone Wealth Management first reported a position in Allergan plc in Q1 2017 and held it in 6 quarters.
  • Cornerstone Wealth Management's Allergan plc position peaked at $452K in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Cornerstone Wealth Management's 13F filing for Q2 2019, filed 2 Aug 2019.